Clinical Trial Update: Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome [NA]

View source ↗

Summary

A randomized study evaluating the use of 3,4-Diaminopyridine for Lambert-Eaton myasthenic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lambert-eaton Myasthenic Syndrome

Drugs mentioned

• 3,4-Diaminopyridine (3,4-diaminopyridine)

Snippet

Sponsor: FDA Office of Orphan Products Development | Conditions: Lambert-Eaton Myasthenic Syndrome | NA | Status: COMPLETED